SNCA and Parkinson disease: Enhancement of autophagy has also been shown to induce clearance of aggregated α-synuclein in vitro and in vivo, supporting the notion that targeting this pathway may be a therapeutic approach for disease modification in PD (Moors et al., 2017; Suresh et al., 2017, 2018).